MSc.-MD-CKII Le Thanh Quynh Ngan, Head of the Hepatitis and Fatty Liver Center, Tam Anh General Hospital, Ho Chi Minh City, said that the virus that causes hepatitis D (HDV) is a virus that only attacks people who are infected with hepatitis B. These two viruses "go together" to accelerate the rate of cirrhosis and liver cancer by 2-3 times. Currently, Vietnam has about 10 million people with hepatitis B. However, most patients have never been screened for hepatitis D, leading to a lack of important data to closely manage cases of co-infection with both viruses.
Technicians at the Testing Center, Tam Anh General Hospital operate the BioDot system (USA) using the Q-MAC technique to help find antibodies to the hepatitis D virus, an agent that can cause liver cancer.
PHOTO: TAM ANH GENERAL HOSPITAL
Dr. Phuong Le Tri, Executive Director of Tam Anh Research Institute, said that the HEP-D study is a joint project between scientists from Tam Anh Research Institute under Tam Anh General Hospital System and Stanford Institute of Microbiology and Epidemiology (USA). This is the first multi-center study according to international standards with the largest scale ever in Vietnam on hepatitis D. The study will be implemented at multiple centers at Tam Anh General Hospital in Hanoi, Tam Anh General Hospital in Ho Chi Minh City and Bach Mai Hospital from November 2025 to July 2026. The goal is to help patients with hepatitis B - D have more opportunities to detect early, proactively manage, treat, and effectively prevent cirrhosis and liver cancer.
The Testing Center of Tam Anh Research Institute and Tam Anh General Hospital is equipped with a modern, specialized and independent system of machinery for research, examination and treatment.
This is one of four important projects that Tam Anh Research Institute and Stanford Institute for Microbiology and Epidemiology have signed a cooperation agreement on since 2023, during the reciprocal state visits of the two governments of Vietnam and the US.
Tam Anh Research Institute, Tam Anh General Hospital System and Stanford University's Institute of Microbiology and Epidemiology at the announcement ceremony of cooperation in training on hepatitis D testing on November 15, 2023
PHOTO: TAM ANH GENERAL HOSPITAL
Doctor Tri said that the current hepatitis D test requires more complicated techniques than the usual hepatitis B test. Therefore, Tam Anh General Hospital System has invested in a synchronous system of specialized modern hepatitis D virus testing equipment worth tens of billions of VND to serve this research.
"The HEP-D study of Tam Anh Research Institute applies international testing standards, equipment and synchronized processes to ensure data is reliable enough to be evaluated and compared with major studies in the world ," said Dr. Tri.
Professor Harry B. Greenberg, "father" of the first generation Rota vaccine, Advisor to the Stanford Institute for Microbiology and Epidemiology (blue shirt) directly visited and worked at the ISO 15189:2012 certified Testing Center at Tam Anh General Hospital, Ho Chi Minh City, from December 2023
PHOTO: TAM ANH GENERAL HOSPITAL
In the hepatitis D study at Tam Anh Research Institute, experts from the Stanford Institute of Microbiology and Epidemiology were directly trained in the Q-MAC technique, using modern specialized systems from BioDot and Odyssey DLx from LI-COR (USA). The technique helps to accurately assess the prevalence of hepatitis D, especially in patients with chronic hepatitis B as in the HEP-D study.
Tam Anh General Hospital also owns a modern Pathology - Cell Center that meets the world's leading standards in pathology such as comprehensive CAP, ISO 15189:2012, and prestigious certification from the American Pathological Society. With leading testing capabilities, Tam Anh aims to become a center for receiving and processing specimens for patients with hepatitis D in the region and internationally.
In addition to its outstanding testing and pathology capabilities, Tam Anh General Hospital System also possesses a series of the world's leading modern specialized technologies and equipment in diagnosing and evaluating diseases closely related to hepatitis B, D and other liver and bile diseases such as the Acuson Sequoia ultrasound system (Siemens, Germany) combined with the new ARFI ultrasound elasticity technique; "super machine" CT system with more than 100,000 slices, 1975-slice CT and 3 Tesla MRI...
The world's leading modern high-end ultrasound system Acuson Sequoia (Siemens, Germany) applies tissue elasticity ultrasound technology to assess the level of fatty liver, liver fibrosis...
PHOTO: TAM ANH GENERAL HOSPITAL
The HEP-D study, conducted by Tam Anh Research Institute, will enroll patients aged 16 and over who have been diagnosed with chronic hepatitis B. Participants will only need to visit once and have a blood test to detect whether they are infected with the hepatitis D virus. All testing costs within the scope of the study will be free. Participants will also receive partial support for travel expenses. Participation is completely voluntary, and patients can withdraw at any time without affecting their regular examination and treatment.
The HEP-D study was first implemented at Tam Anh General Hospital System in Hanoi and Ho Chi Minh City, and then expanded to recruit patients at Bach Mai Hospital, Hanoi.
At Tam Anh General Hospital System, patients participating in the study will be consulted by doctors from the Hepatitis and Fatty Liver Center and undergo hepatitis D screening steps. If you or your relatives want to learn more about this study and register to participate, please contact the hotline: 0287 102 6789 (HCMC) and 0247 106 6858 (Hanoi) or via email cskh@tahospital.vn .
Thanhnien.vn
Source: https://thanhnien.vn/viet-nam-xet-nghiem-viem-gan-d-chuan-my-mien-phi-gan-2500-ca-toan-quoc-185251124203919987.htm
Comment (0)